Here’s Why These Five Stocks Are on the Move on Thursday

Staples, Inc. (NASDAQ:SPLS)’s stock is 3% in the red so far on Thursday, after the company reported revenue of $4.5 billion for the second quarter, missing analysts’ estimates by $20 million, while EPS of $0.12 was in line with expectations. The failed merger with Office Depot Inc (NASDAQ:ODP) has costed Staples $1 billion in charges. Staples also booked charges related to impairment of European goodwill and other assets in this quarter in addition to the termination fee. Among the investors in our database, Pzena Investment Management holds around 33.90 million shares of Staples according to its 13F filing for the end of June.

L Brands Inc (NYSE:LB)’s stock has advanced by 4.60% on the back of the company’s better-than-expected results for the second quarter. The company reported revenue of $2.89 billion, which topped estimates by $30 million, while EPS of $0.70 was higher than analysts’ forecasts of $0.59. For the third quarter, L Brands Inc (NYSE:LB) expects EPS to be in the range of $0.40 to $0.45, while full-year EPS guidance is between $3.79 and $3.94. During the second quarter, Alex Snow’s Lansdowne Partners increased its stake in L Brands by 27% to 11.07 million shares.

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) has gained around 10% after Bloomberg reported that Retrophin might be interested in acquiring Raptor. Citing people familiar with the matter, Bloomberg said that companies have not reached an agreement and other companies are also interested in buying Raptor pharmaceuticals. Retrophin was founded by infamous entrepreneur Martin Shkreli, who had resigned from the company in 2014 and last year was accused of defrauding investors through his hedge fund. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) is currently working on Huntington’s disease and cystic fibrosis. During the second quarter, Kevin Kotler’s Broadfin Capital reduced its stake in Raptor Pharmaceuticals by 8% to 6.45 million shares.

Disclosure: None